Cargando…
MYCN and Metabolic Reprogramming in Neuroblastoma
SIMPLE SUMMARY: Metabolic reprogramming has a central role in the initiation and progression of cancer, including high-risk neuroblastoma, a deadly childhood malignant tumor of the sympathetic nervous system. This rewiring of cellular metabolism increases the manufacture of fuel and building blocks...
Autores principales: | Bansal, Mohit, Gupta, Anamika, Ding, Han-Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455056/ https://www.ncbi.nlm.nih.gov/pubmed/36077650 http://dx.doi.org/10.3390/cancers14174113 |
Ejemplares similares
-
A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma
por: Zhang, Hai-Feng, et al.
Publicado: (2023) -
MYCN Amplifications and Metabolic Rewiring in Neuroblastoma
por: Pouliou, Marialena, et al.
Publicado: (2023) -
Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification
por: Talapatra, Jyotirmayee, et al.
Publicado: (2023) -
Exploitation of chick embryo environments to reprogram MYCN-amplified neuroblastoma cells to a benign phenotype, lacking detectable MYCN expression
por: Carter, R, et al.
Publicado: (2012) -
MYCN in Neuroblastoma: “Old Wine into New Wineskins”
por: Braoudaki, Maria, et al.
Publicado: (2021)